Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RING | 78.05 | 2.16 | +2.85% |
| iShares MSCI Global Gold Miners ETF (RING) | |||
| FLDB | 50.26 | 0.01 | +0.02% |
| Fidelity Low Duration Bond ETF (FLDB) | |||
| ODHY | 9.83 | N/A | N/A |
| Obra Defensive High Yield ETF (ODHY) | |||
| SLDR | 49.36 | -0.05 | -0.10% |
| Global X Short-Term Treasury Ladder ETF (SLDR) | |||
| QVMT | 65.44 | -0.14 | -0.21% |
| Invesco S&P 500 Concentrated QVM ETF (QVMT) | |||
Industry Biotechnology